GlassScriptPhysician profile
Gretchen Ann Champion
NPI 1104869866
$1,465.27
in general payments reported to CMS, 2019-2025
14 companies · $402 in 2025
The $402 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $425 · 2020: $75.55 · 2021: $106 · 2022: $58.15 · 2023: $271 · 2024: $127 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $327.68 | 2019-2024 | Xpress Loprofile |
| Integra Lifesciences Corporation | $193.59 | 2024-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Zoll Respicardia, INC. | $143.52 | 2023 | Remede System |
| Genzyme Corporation | $119.61 | 2022-2025 | |
| Neurent Medical Limited | $119.41 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Olympus America INC. | $119.22 | 2019 | |
| Acclarent, INC | $110.97 | 2019-2023 | Trudi Nav Cable |
| Optinose US, INC. | $96.76 | 2021-2024 | |
| Aerin Medical INC. | $86.21 | 2023-2025 | |
| Intersect Ent, INC. | $40.91 | 2019 | |
| Hikma Pharmaceuticals USA | $35.51 | 2024-2025 | Ryaltris |
| Inspire Medical Systems, INC. | $28.29 | 2023 | Inspire |
| Cochlear Americas | $21.89 | 2019 | |
| Medtronic, INC. | $21.70 | 2024 | Propel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gretchen Champion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.